InsiderTrades.com logo
Top Analyst Exposes Imminent Crisis Hurtling Towards America
From Porter and Company   |   Ad
The man who warned of the dot-com blow up, the 2008 housing collapse, and the loss of America’s AAA rating makes a shocking prediction…
Watch the most eye-opening film of the year for free
Jose-Carlos Gutierrez-Ramos net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

Jose-Carlos Gutierrez-Ramos Biography and Net Worth

SVP of Danaher
Jose-Carlos (“JC”) is Senior Vice President and Chief Science Officer of Danaher. In this role, JC is responsible for setting Danaher’s science and technology strategy, supporting M&A and open innovation, and counseling Danaher’s operating companies on innovation opportunities. He leads the Danaher Innovation Centers and the Danaher Scientific Advisory Board. Working with technical leaders across Danaher, JC enables innovation best practice sharing and culture building.

“Science and technology is a powerful motivator for me and for many Danaher associates. We get up each day with a passion and goal to help solve our customers’ most complex challenges. Looking ahead the next five to ten years, we see tremendous opportunity to improve human health through scientific research and discovery.”

JC has diverse leadership experience across multiple biotech start-ups and pharmaceutical companies and deep expertise in translating new areas of science and technology into successful drug discovery and development programs and marketed drugs. Prior to Danaher, JC served as Global Head of Drug Discovery at AbbVie, Group SVP Biotherapeutics R&D at Pfizer and SVP and CEDD Head of Inmuno Inflammation at GlaxoSmithKline. JC was the founding CEO and President at Repertoire Immune Medicine where he built and led a team to decode the human immunome. Previously, he was President and CEO of Synlogic, where he led the company from early discovery to the clinical stage and to the public markets. In these global positions, he oversaw multiple drug discovery teams, resulting in five marketed drugs.

JC has a Ph.D. in immunology from the Universidad Autonoma de Madrid and trained as an immunologist in Spain, Germany and Switzerland. He started his academic career as Assistant Professor of Genetics at Harvard Medical School. He has authored more than 150 peer-reviewed publications.

What is Jose-Carlos Gutierrez-Ramos' net worth?

The estimated net worth of Jose-Carlos Gutierrez-Ramos is at least $1.72 million as of August 21st, 2023. Dr. Gutierrez-Ramos owns 6,939 shares of Danaher stock worth more than $1,715,598 as of September 28th. This net worth approximation does not reflect any other investments that Dr. Gutierrez-Ramos may own. Additionally, Dr. Gutierrez-Ramos receives an annual salary of $2,240,000.00 as SVP at Danaher. Learn More about Jose-Carlos Gutierrez-Ramos' net worth.

How old is Jose-Carlos Gutierrez-Ramos?

Dr. Gutierrez-Ramos is currently 60 years old. There are 7 older executives and no younger executives at Danaher. The oldest executive at Danaher is Mr. Steven M. Rales, Co-Founder & Chairman, who is 72 years old. Learn More on Jose-Carlos Gutierrez-Ramos' age.

What is Jose-Carlos Gutierrez-Ramos' salary?

As the SVP of Danaher Co., Dr. Gutierrez-Ramos earns $2,240,000.00 per year. There are 4 executives that earn more than Dr. Gutierrez-Ramos. The highest earning executive at Danaher is Mr. Rainer M. Blair, Pres, CEO & Director, who commands a salary of $5,930,000.00 per year. Learn More on Jose-Carlos Gutierrez-Ramos' salary.

How do I contact Jose-Carlos Gutierrez-Ramos?

The corporate mailing address for Dr. Gutierrez-Ramos and other Danaher executives is 2200 PENNSYLVANIA AVE. N.W SUITE 800W, WASHINGTON DC, 20037. Danaher can also be reached via phone at (202) 828-0850 and via email at [email protected]. Learn More on Jose-Carlos Gutierrez-Ramos' contact information.

Has Jose-Carlos Gutierrez-Ramos been buying or selling shares of Danaher?

Within the last three months, Jose-Carlos Gutierrez-Ramos has sold $147,818.60 in shares of Danaher stock. Most recently, Jose-Carlos Gutierrez-Ramos sold 590 shares of the business's stock in a transaction on Monday, August 21st. The shares were sold at an average price of $250.54, for a transaction totalling $147,818.60. Following the completion of the sale, the senior vice president now directly owns 6,939 shares of the company's stock, valued at $1,738,497.06. Learn More on Jose-Carlos Gutierrez-Ramos' trading history.

Who are Danaher's active insiders?

Danaher's insider roster includes Rainer Blair (EVP), Daniel Comas (EVP), William Daniel (EVP), Brian Ellis (SVP), Linda Filler (Director), Jose-Carlos Gutierrez-Ramos (SVP), Linda Hefner (Director), Jennifer Honeycutt (EVP), Thomas Joyce, Jr. (CEO), William King (SVP), Angela Lalor (SVP), Angela Lalor (SVP), Teri List (Director), Walter Lohr (Director), Robert Lutz (CAO), Matthew McGrew (CFO), Mitchell Rales (Chairman), Daniel Raskas (SVP), John Schwieters (Director), Alan Spoon (Director), Raymond Stevens (Director), Joakim Weidemanis (EVP), and Elias Zerhouni (Director). Learn More on Danaher's active insiders.

Are insiders buying or selling shares of Danaher?

In the last twelve months, insiders at the conglomerate sold shares 16 times. They sold a total of 129,836 shares worth more than $33,429,273.40. The most recent insider tranaction occured on August, 21st when SVP Jose-Carlos Gutierrez-Ramos sold 590 shares worth more than $147,818.60. Insiders at Danaher own 11.1% of the company. Learn More about insider trades at Danaher.

Information on this page was last updated on 8/21/2023.

Jose-Carlos Gutierrez-Ramos Insider Trading History at Danaher

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/21/2023Sell590$250.54$147,818.606,939View SEC Filing Icon  
5/1/2023Sell500$242.19$121,095.007,529View SEC Filing Icon  
See Full Table

Jose-Carlos Gutierrez-Ramos Buying and Selling Activity at Danaher

This chart shows Jose-Carlos Gutierrez-Ramos's buying and selling at Danaher by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Danaher Company Overview

Danaher logo
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, municipal, industrial, and natural resource applications. It also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. The company was founded in 1969 and is headquartered in Washington, the District of Columbia.
Read More

Today's Range

Now: $247.24
Low: $246.89
High: $249.94

50 Day Range

MA: $255.33
Low: $244.38
High: $265.59

2 Week Range

Now: $247.24
Low: $221.22
High: $283.63

Volume

2,284,683 shs

Average Volume

2,839,511 shs

Market Capitalization

$182.55 billion

P/E Ratio

29.02

Dividend Yield

0.43%

Beta

0.8
The Safest Option in Trades!
From Tradewins   |   Ad
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!